149 related articles for article (PubMed ID: 6802677)
1. Influence of danazol treatment during the luteal phase on pituitary and ovarian function during the subsequent menstrual cycle.
Fraser IS; Markham R; Robinson M; Thorburn GD
Fertil Steril; 1982 Apr; 37(4):489-93. PubMed ID: 6802677
[TBL] [Abstract][Full Text] [Related]
2. Investigation of Danazol as a contraceptive agent.
Wentz AC; Jones GS; Sapp KC
Contraception; 1976 May; 13(5):619-30. PubMed ID: 1261264
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition by danazol of follicle stimulating hormone during the luteal phase.
Lieberman BA; Thom S; Murray MA; Jacobs HS
Br J Obstet Gynaecol; 1977 Jan; 84(1):55-7. PubMed ID: 321001
[TBL] [Abstract][Full Text] [Related]
4. Danazol: endocrine consequences in healthy women.
Luciano AA; Hauser KS; Chapler FK; Sherman BM
Am J Obstet Gynecol; 1981 Nov; 141(6):723-7. PubMed ID: 6797301
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys.
Molskness TA; Woodruff TK; Hess DL; Dahl KD; Stouffer RL
J Clin Endocrinol Metab; 1996 Nov; 81(11):4002-6. PubMed ID: 8923851
[TBL] [Abstract][Full Text] [Related]
6. Dynamic tests of hypothalamic and pituitary function in women treated with danazol.
Fraser IS; Markham R; McIlveen J; Robinson M
Fertil Steril; 1982 Apr; 37(4):484-8. PubMed ID: 6802676
[TBL] [Abstract][Full Text] [Related]
7. Follicular fluid treatment during the follicular versus luteal phase of the menstrual cycle: effects on corpus luteum function.
Stouffer RL; Hodgen GD; Ottobre AC; Christian CD
J Clin Endocrinol Metab; 1984 Jun; 58(6):1027-33. PubMed ID: 6427256
[TBL] [Abstract][Full Text] [Related]
8. Human recombinant activin-A alters pituitary luteinizing hormone and follicle-stimulating hormone secretion, follicular development, and steroidogenesis, during the menstrual cycle in rhesus monkeys.
Stouffer RL; Woodruff TK; Dahl KD; Hess DL; Mather JP; Molskness TA
J Clin Endocrinol Metab; 1993 Jul; 77(1):241-8. PubMed ID: 8325947
[TBL] [Abstract][Full Text] [Related]
9. Progestational activity of danazol in the human female subject.
Wentz AC; Jones GS; Sapp KC; King TM
Am J Obstet Gynecol; 1976 Oct; 126(3):378-84. PubMed ID: 961786
[TBL] [Abstract][Full Text] [Related]
10. The influence of danazol on pituitary function and on the ovarian follicular hormone secretion in premenopausal women.
Rannevik G; Thorell JI
Acta Obstet Gynecol Scand Suppl; 1984; 123():89-94. PubMed ID: 6437127
[TBL] [Abstract][Full Text] [Related]
11. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
12. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
[TBL] [Abstract][Full Text] [Related]
13. Endocrine effects of danazol in menstruating women.
Guillebaud J; Fraser IS; Thorburn GD; Jenken G
J Int Med Res; 1977; 5 Suppl 3():57-66. PubMed ID: 913882
[No Abstract] [Full Text] [Related]
14. The effects of danazol on the pituitary-ovarian axis in the Rhesus monkey (Macaca mulatta).
Jenkin G; Fraser IS; Challis JR; Elvidge H; Thorburn GD
J Int Med Res; 1977; 5 Suppl 3():44-56. PubMed ID: 410687
[No Abstract] [Full Text] [Related]
15. Effects of danazol on pulsatile gonadotropin patterns and on serum estradiol levels in normally cycling women.
Dmowski WP; Headley S; Radwanska E
Fertil Steril; 1983 Jan; 39(1):49-55. PubMed ID: 6401252
[TBL] [Abstract][Full Text] [Related]
16. Hypersensitivity of the human gonadotrophs to the repeated administration of small doses of LH-RH.
Faure N; Olivier GC
Horm Res; 1978; 9(1):12-21. PubMed ID: 338460
[TBL] [Abstract][Full Text] [Related]
17. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
[TBL] [Abstract][Full Text] [Related]
18. The effect of danazol on gonadotropin secretion during the follicular phase of the menstrual cycle.
Braun P; Wildt L; Leyendecker G
Fertil Steril; 1983 Jul; 40(1):37-44. PubMed ID: 6345207
[TBL] [Abstract][Full Text] [Related]
19. Short-term endocrine response to gonadotropin-releasing hormone agonist initiated in the early follicular, midluteal, or late luteal phase in normally cycling women.
Gelety TJ; Pearlstone AC; Surrey ES
Fertil Steril; 1995 Dec; 64(6):1074-80. PubMed ID: 7589655
[TBL] [Abstract][Full Text] [Related]
20. Prolonged inhibition of normal ovarian cycles in the rat and cynomolgus monkeys following a single s.c. injection of danazol.
Butterstein GM; Mann DR; Gould K; Castracane VD
Hum Reprod; 1997 Jul; 12(7):1409-15. PubMed ID: 9262267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
